Stories
Slash Boxes
Comments
typodupeerror delete not in
  • Preferences

+-   The post-Bilski era gets underway-> on Friday December 19 2008, @04:08PM bfwebster

Submitted by bfwebster on Friday December 19 2008, @04:08PM
patents
bfwebster writes "A set of pharmaceutical process patents for "evaluating and improving the safety of immunization schedules" (Classen v. Biogen et al.; see US Patents 6,420,139; 6,638,379; 5,728,385; 5,723,283) were held to be invalid due to unpatentability. The decision was appealed to the US Court of Appeals for the Federal Circuit, but was upheld with a terse citation to In re Bilksi. Here's the entire text of the appeals decision:

In light of our decision in In re Bilski, 545 F.3d 943 (Fed. Cir. 2008) (en banc), we affirm the district court's grant of summary judgment that these claims are invalid under 35 U.S.C. 101. Dr. Classen's claims are neither "tied to a particular machine or apparatus" nor do they "transform[] a particular article into a different state or thing." Bilski, 545 F.3d at 954. Therefore we affirm.

It will be interesting to see what happens when these same standards are applied to software-related patents."
Link to Original Source

submission
This discussion was created for logged-in users only, but now has been archived. No new comments can be posted.
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.

The post-Bilski era gets underway 0 Comments More /

 Full
 Abbreviated
 Hidden
More
Loading... please wait.
Search
The man who raises a fist has run out of ideas. -- H.G. Wells, "Time After Time"

All trademarks and copyrights on this page are owned by their respective owners. Comments are owned by the Poster. The Rest © 1997-2010 Geeknet, Inc.